Category : Search result: Donald Trump approval rating


Stalin Demands Timeline for Governor Bill Approval

Tamil Nadu CM MK Stalin intensifies pressure on Governor RN Ravi, demanding clear timelines for bill approvals. The DMK government vows continued protest until constitutional crisis resolved.

Pine Labs shares fall after Emkay 'reduce' rating

Pine Labs shares declined 2.8% after Emkay Global initiated coverage with 'reduce' rating and ₹210 target price. Learn about the three bearish triggers affecting the fintech stock.

US Approves $93M Defence Deal with India for Advanced Weapons

The United States has approved a $93 million defence deal supplying India with Javelin missile systems and Excalibur artillery projectiles. This strategic partnership enhances India's military capabilities against regional threats. Read more about this si

MP Cabinet Approves Housing & Welfare Schemes

Madhya Pradesh Cabinet chaired by CM Dr Mohan Yadav approves multiple decisions including housing schemes, welfare measures, and administrative approvals. Key focus on public welfare and development.

WeWork India surges 8% on Jefferies Buy rating

WeWork India shares jumped nearly 8% after Jefferies initiated coverage with Buy rating and ₹790 price target. The brokerage sees 29% upside potential in flexible workspace leader.

3 Stocks to Watch After Cabinet's Export Mission

Indian cabinet approves ₹25,060 crore export promotion mission. Discover three stocks poised to benefit from the MSME and export-focused initiative. Add these to your watchlist now.

Musk Gets $1 Trillion Tesla Pay, Dances With Robot

Tesla shareholders approve Elon Musk's nearly $1 trillion compensation package. The billionaire celebrated by dancing with Optimus humanoid robot at annual meeting. Read more about this historic deal.

Granules India Gets USFDA Approval for Hyderabad Plant

Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.

Sebi Approves Clean Max & NephroPlus IPOs

SEBI greenlights IPOs for Clean Max Enviro Energy Solutions (₹5,200 cr) and NephroPlus (₹353 cr). Get key details on fund utilization, OFS, and investment insights. Read more.

Page 1 of 4